1251 |
FEXFAD TABLET 120 MG |
FEXOFENADINE HYDROCHLORIDE 120 MG |
TABLET |
ALU-ALU BLISTERPACK |
RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 12 YEARS AND OLDER |
No |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
FOCUS & RULZ PHARMACEUTICALS (PVT) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
06 I 4743/19 |
2022-09-26 |
2025-09-25 |
View |
1252 |
FEXFAD TABLET 60 MG |
FEXOFENADINE HYDROCHLORIDE 60 MG |
TABLET |
ALU-ALU BLISTERPACK |
RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 12 YEARS AND OLDER |
No |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
FOCUS & RULZ PHARMACEUTICALS (PVT) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
06 I 4744/19 |
2022-09-26 |
2025-09-25 |
View |
1253 |
FLURIN CAPSULE |
FLUNARIZINE HYDROCHLORIDE 5 MG |
CAPSULE |
PVC/ALU BLISTERPACK |
IT HAS ANTIHISTAMINE, SEDATIVE AND CALCIUM - CHANNEL BLOCKING ACTIVITY. FLUNARIZINE HYDROCHLORIDE IS USED FOR MIGRAINE PROPHYLAXIS, FOR VERTIGO AND VESTIBULAR DISORDERS AND FOR PERIPHERAL AND CEREBRAL VASCULAR DISORDERS. |
No |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
T.MAN PHARMA CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 4255/17 |
2024-07-09 |
2027-07-08 |
View |
1254 |
I-BUFEN SUSPENSION |
IBUPROFEN 100 MG/5 ML |
SUSPENSION |
BOTTLE |
RELIEF OF PAIN INCLUDING SOFT TISSUE INJURIES, MENSTRUAL CRAMPS (DYSMENORRHEA), DENTAL PAIN, HEADACHE, REDUCE FEVER. FOR TREATMENT OF INFLAMMATIONS INCLUDING OSTEOARTHRITIS AND MUSCULOSKELETAL DISORDERS. |
No |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
T.MAN PHARMA COMPANY LIMITED |
THAILAND |
CERTIFICATE RELEASED |
06 I 5551/23 |
2023-06-26 |
2026-06-25 |
View |
1255 |
KRESSMOL-250 SYRUP |
PARACETAMOL 250 MG/5 ML |
SYRUP |
BOTTLE |
ANALGESIC AND ANTIPYRETIC |
Yes |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
SEVENSTARS PHARMACEUTICAL CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
06 I 4468/18 |
2022-07-22 |
2025-07-21 |
View |
1256 |
LAKAS TABLET 10 MG |
MONTELUKAST SODIUM EQ. TO MONTELUKAST 10 MG |
TABLET |
ALU-ALU |
TREATMENT OF ASTHMA AS ADD-ON THERAPY IN ADULTS AND CHILDREN WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA-AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA. |
Yes |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
FOCUS & RULZ PHARMACEUTICALS (PVT) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4667/19 |
2024-06-22 |
2027-06-21 |
View |
1257 |
LAKAS TABLET 5 MG |
MONTELUKAST SODIUM EQ. TO MONTELUKAST 5 MG |
TABLET |
ALU-ALU |
TREATMENT OF ASTHMA AS ADD-ON THERAPY IN ADULTS AND CHILDREN WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA-AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA. |
Yes |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
FOCUS & RULZ PHARMACEUTICALS (PVT) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4666/19 |
2024-06-22 |
2027-06-21 |
View |
1258 |
MAGNESUM |
EACH 15 ML CONTAINS : DRIED ALUMINIUM HYDROXIDE GEL 300 MG EQ.TO ALUMINIUM HYDROXIDE 229 MG, MAGNESIUM HYDROXIDE 75 MG, SIMETHICONE 30 MG
|
SUSPENSION |
Bottle |
FOR TEMPORARY REDUCTION OF GASTRIC HYPERACIDITY AND SYMPTOMATIC RELIEF OF PEPTIC ULCER |
No |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
B.M. PHARMACY CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 4256/17 |
2024-02-07 |
2027-02-06 |
View |
1259 |
MEFMIC 500 |
MEFENAMIC ACID 500 MG |
TABLET |
BLISTERPACK |
FOR THE SYMPTOMATIC RELIEF OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, AND PAIN INCLUDING MUSCULAR, PAIN, HEADACHES AND DYSMENORRHOEA |
Yes |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
BUKALO TRADING CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
09 I 4590/18 |
2022-08-05 |
2025-08-04 |
View |
1260 |
MYOPAS TABLET |
PARACETAMOL 450 MG, ORPHENADRINE CITRATE 35 MG |
TABLET |
ALU-ALU STRIP |
FOR THE TREATMENT OF MILD TO MODERATE PAIN INCLUDING HEADACHE, MIGRAINE, NEURALGIA, TOOTHACHE, SORE THROAT, PERIOD PAINS, ACHES AND PAINS, SYMPTOMATIC RELIEF OF RHEUMATIC ACHES AND PAINS AND OF INFLUENZA, FEVERISHNESS AND FEVERISH COLDS. |
No |
KONGCHAI-LAO PHARMA SOLE CO.,LTD |
T.MAN PHARMA CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
05 I 4265/17 |
2024-07-09 |
2027-07-08 |
View |